Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine kinase activity	PRKD2 MAK ILK ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	6.60e-06	363	158	13	GO:0106310
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	PRKD2 MAK ILK ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	5.69e-05	446	158	13	GO:0004674
GeneOntologyMolecularFunction	protein kinase activity	PRKD2 MAK ILK INSRR ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	3.04e-04	600	158	14	GO:0004672
GeneOntologyMolecularFunction	cytoskeletal protein binding	SHROOM3 KIF23 SPATA6 ANK1 TRPC5 APC2 APC EPB41L5 CCDC88B BRCA2 FMN1 STARD9 LRRC27 VASH2 SSH2 GNAS KIF18B CORO7 PSRC1 KLHL4	4.35e-04	1099	158	20	GO:0008092
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	PRKD2 MAK ILK INSRR ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 NADK MAP3K13 DCLK1 MAST3 MAP3K19	5.20e-04	709	158	15	GO:0016773
GeneOntologyMolecularFunction	tubulin binding	KIF23 APC2 APC CCDC88B BRCA2 FMN1 STARD9 VASH2 GNAS KIF18B PSRC1	6.19e-04	428	158	11	GO:0015631
Domain	Ser/Thr_kinase_AS	PRKD2 MAK ILK ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	9.74e-06	357	156	13	IPR008271
Domain	PROTEIN_KINASE_ST	PRKD2 MAK ILK ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	1.13e-05	362	156	13	PS00108
Domain	PROTEIN_KINASE_ATP	PRKD2 MAK ILK INSRR ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	3.19e-05	459	156	14	PS00107
Domain	S_TKc	PRKD2 MAK ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	4.99e-05	359	156	12	SM00220
Domain	Kinase-like_dom	PRKD2 MAK ILK RAPH1 INSRR ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	5.04e-05	542	156	15	IPR011009
Domain	Prot_kinase_dom	PRKD2 MAK ILK INSRR ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	6.31e-05	489	156	14	IPR000719
Domain	PROTEIN_KINASE_DOM	PRKD2 MAK ILK INSRR ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	6.89e-05	493	156	14	PS50011
Domain	cwf21	U2SURP SRRM2	6.93e-05	2	156	2	PF08312
Domain	APC_r	APC2 APC	6.93e-05	2	156	2	PF05923
Domain	SAMP	APC2 APC	6.93e-05	2	156	2	PF05924
Domain	APC_dom	APC2 APC	6.93e-05	2	156	2	IPR026831
Domain	APC_N	APC2 APC	6.93e-05	2	156	2	IPR032038
Domain	APC_basic_dom	APC2 APC	6.93e-05	2	156	2	IPR009234
Domain	Apc_fam	APC2 APC	6.93e-05	2	156	2	IPR026818
Domain	APC_rpt	APC2 APC	6.93e-05	2	156	2	IPR009223
Domain	SAMP	APC2 APC	6.93e-05	2	156	2	IPR009224
Domain	mRNA_splic_Cwf21_dom	U2SURP SRRM2	6.93e-05	2	156	2	IPR013170
Domain	APC_basic	APC2 APC	6.93e-05	2	156	2	PF05956
Domain	Filaggrin	FLG FLG2	6.93e-05	2	156	2	IPR003303
Domain	APC_N_CC	APC2 APC	6.93e-05	2	156	2	PF16689
Domain	Pkinase	PRKD2 MAK ERN2 WNK1 MAP3K3 CAMKK2 MAST4 CDK13 MAP3K13 DCLK1 MAST3 MAP3K19	8.79e-05	381	156	12	PF00069
Domain	PLAC	THSD4 PCSK6 ADAMTSL2	1.94e-04	14	156	3	PF08686
Domain	FRG2	FRG2 FRG2B	2.07e-04	3	156	2	PF15315
Domain	FRG2	FRG2 FRG2B	2.07e-04	3	156	2	IPR026245
Domain	DUF1908	MAST4 MAST3	4.11e-04	4	156	2	PF08926
Domain	MA_Ser/Thr_Kinase_dom	MAST4 MAST3	4.11e-04	4	156	2	IPR015022
Domain	MAST_pre-PK_dom	MAST4 MAST3	4.11e-04	4	156	2	IPR023142
Domain	-	MAST4 MAST3	4.11e-04	4	156	2	1.20.1480.20
Domain	PLAC	THSD4 PCSK6 ADAMTSL2	5.02e-04	19	156	3	PS50900
Domain	PLAC	THSD4 PCSK6 ADAMTSL2	5.02e-04	19	156	3	IPR010909
Domain	-	CAND2 APC2 APC RICTOR HEATR5A ODAD2 CUL7 XPOT	5.65e-04	222	156	8	1.25.10.10
Domain	ARM-type_fold	GBF1 CAND2 NOC2L APC2 APC RICTOR HEATR5A ODAD2 CUL7 XPOT	5.74e-04	339	156	10	IPR016024
Domain	SURP	SFSWAP U2SURP	1.02e-03	6	156	2	PS50128
Domain	Surp	SFSWAP U2SURP	1.02e-03	6	156	2	PF01805
Domain	SWAP	SFSWAP U2SURP	1.02e-03	6	156	2	SM00648
Domain	Surp	SFSWAP U2SURP	1.02e-03	6	156	2	IPR000061
Domain	Ankyrin_rpt	ILK ANK1 RAPH1 TRPC5 CAMTA2 GIT2 PPP1R16B AGAP2	1.64e-03	262	156	8	IPR002110
Domain	ARM-like	CAND2 APC2 APC RICTOR HEATR5A ODAD2 CUL7 XPOT	1.98e-03	270	156	8	IPR011989
Domain	Arm	APC2 APC ODAD2	2.16e-03	31	156	3	PF00514
Domain	Ank	ILK ANK1 TRPC5 CAMTA2 GIT2 PPP1R16B AGAP2	3.09e-03	228	156	7	PF00023
Domain	RABBD	EXPH5 RIMS2	4.33e-03	12	156	2	PS50916
Domain	Rab_BD	EXPH5 RIMS2	4.33e-03	12	156	2	IPR010911
Domain	ARM_REPEAT	APC2 APC ODAD2	4.50e-03	40	156	3	PS50176
Domain	ARM	APC2 APC ODAD2	4.50e-03	40	156	3	SM00185
Domain	Kinesin_motor_CS	KIF23 STARD9 KIF18B	4.83e-03	41	156	3	IPR019821
Domain	-	ILK ANK1 TRPC5 CAMTA2 GIT2 PPP1R16B AGAP2	4.89e-03	248	156	7	1.25.40.20
Domain	ANK_REPEAT	ILK ANK1 TRPC5 CAMTA2 GIT2 PPP1R16B AGAP2	5.44e-03	253	156	7	PS50088
Domain	Ankyrin_rpt-contain_dom	ILK ANK1 TRPC5 CAMTA2 GIT2 PPP1R16B AGAP2	5.55e-03	254	156	7	IPR020683
Domain	ANK_REP_REGION	ILK ANK1 TRPC5 CAMTA2 GIT2 PPP1R16B AGAP2	5.55e-03	254	156	7	PS50297
Domain	-	KIF23 STARD9 KIF18B	5.89e-03	44	156	3	3.40.850.10
Domain	Kinesin	KIF23 STARD9 KIF18B	5.89e-03	44	156	3	PF00225
Domain	KISc	KIF23 STARD9 KIF18B	5.89e-03	44	156	3	SM00129
Domain	KINESIN_MOTOR_1	KIF23 STARD9 KIF18B	5.89e-03	44	156	3	PS00411
Domain	Kinesin_motor_dom	KIF23 STARD9 KIF18B	5.89e-03	44	156	3	IPR001752
Domain	KINESIN_MOTOR_2	KIF23 STARD9 KIF18B	5.89e-03	44	156	3	PS50067
Domain	PDZ	SHROOM3 MAST4 RIMS2 MAST3 PDZD2	6.64e-03	141	156	5	PF00595
Domain	Armadillo	APC2 APC ODAD2	7.08e-03	47	156	3	IPR000225
Domain	PDZ	SHROOM3 MAST4 RIMS2 MAST3 PDZD2	8.10e-03	148	156	5	SM00228
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SRRM1 NCOA6 SHROOM3 KIF23 GBF1 ILK USP22 TRA2B RAPH1 NET1 KDM5A EXPH5 APC EPB41L5 RICTOR WNK1 MAP3K3 CDC42EP1 CEP170 C2CD3 MAST4 KCNQ5 STARD9 KIAA1217 NADK NHS SSH2 GNAS SRRM2 DOCK6 DCLK1	1.12e-18	861	164	31	36931259
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	SRRM1 KIF23 GBF1 TRA2B GIT2 WNK1 CCNY CEP170 NADK TRA2A ACIN1 SRRM2	3.64e-09	255	164	12	15324660
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PITPNM2 PRKD2 NCOA6 SHROOM3 GBF1 PCNX3 MRPL55 POM121C WNK1 PLEKHH3 ORC1 SCAF1 NCOR1 C2CD3 CDK13 TMCC2 NADK C19orf44 MLLT6 DOCK6 IQCE MYBL2	1.35e-08	1105	164	22	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GBF1 EXPH5 GRAMD1A EPB41L5 RICTOR CUL7 POM121C WNK1 CEP170 CDK13 TMCC2 ASTN2 SSH2 MAST3 ADAMTSL2	1.45e-08	493	164	15	15368895
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SRRM1 KIF23 GBF1 TRA2B RAPH1 PNISR CCDC88B CEP170 SCAF1 CDK13 NADK TRA2A SRRM2	1.96e-08	361	164	13	26167880
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TICRR CAND2 NET1 ZNF652 APC FBXO11 RICTOR CAMTA2 WNK1 ZRANB3 MAP3K3 CHST8 FMN1 NADK ACIN1 MTO1 SLC33A1 DCLK1 XPOT RAD17 NPAT	4.72e-08	1084	164	21	11544199
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SRRM1 TICRR NCOA6 KIF23 SFSWAP TRA2B KDM5A NOC2L U2SURP FBXO11 GPATCH4 POM121C PNISR RYBP ORC1 SCAF1 NCOR1 CDK13 TRA2A ACIN1 KIF18B SRRM2 MYBL2	4.90e-08	1294	164	23	30804502
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SRRM1 NCOA6 KIF23 PDE4C GBF1 SFSWAP RAPH1 KDM5A RICTOR PNISR CCNY SCAF1 NCOR1 CDK13 ACIN1 SRRM2 MYBL2	1.73e-07	774	164	17	15302935
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PRKD2 SRRM1 USP22 SFSWAP NET1 KDM5A RICTOR GPATCH4 CUL7 POM121C ZC3H3 GJD4 CDC42EP1 CEP170 SCAF1 PCSK6 ZNF324 MTO1 KIF18B SRRM2	3.48e-07	1116	164	20	31753913
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	SRRM1 TRA2B RAPH1 KDM5A APC STARD9 KIAA1217 TRA2A ACIN1 SRRM2 MAST3	1.29e-06	361	164	11	30344098
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	SCAF1 PARP10 NCOR1 KCNQ5 STARD9 MCM9 SRRM2 IQCE PGBD2	1.79e-06	233	164	9	37704626
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FLG SRRM1 USP22 SFSWAP TRA2B KDM5A MRPL55 U2SURP APC FBXO11 FLG2 PNISR CEP170 ZNF324 TRA2A ACIN1 SRRM2 DOCK6	3.95e-06	1082	164	18	38697112
Pubmed	SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.	SRRM1 TRA2B PCNX3 NOC2L SCAF1 CDK13 TRA2A ACIN1 SRRM2	4.25e-06	259	164	9	30404004
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	SRRM1 KIF23 TRA2B APC WNK1 NCOR1 CDK13 TRA2A ACIN1 NHS SRRM2 PSRC1	5.28e-06	503	164	12	16964243
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOA6 SHROOM3 GBF1 APC2 DDN POM121C WNK1 ZRANB3 NCOR1 MLLT6 IQCE	6.87e-06	430	164	11	35044719
Pubmed	Global phosphoproteome of HT-29 human colon adenocarcinoma cells.	PRKD2 NOC2L CEP170 ACIN1 SRRM2	8.94e-06	59	164	5	16083285
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	PITPNM2 PRKD2 RAPH1 NOC2L RICTOR WNK1 PNISR MAP3K3 CDC42EP1 CEP170 KIAA1217 C19orf44 LSM11 SSH2 GNAS DOCK6 PSRC1	9.12e-06	1038	164	17	26673895
Pubmed	The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.	TRA2B POM121C SRRM2 NPAT	1.03e-05	29	164	4	17577209
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	U2SURP WNK1 MAST4 SRRM2 DCLK1 PDZD2	1.04e-05	104	164	6	9205841
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	CACNB4 ANK1 FGA RIMS2 SRRM2 DCLK1 MAST3 AGAP2	1.51e-05	231	164	8	16452087
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SRRM1 KIF23 ILK KDM5A FBXO11 RICTOR GPATCH4 WNK1 SCAF1 BRF1 CDK13 MCM9 SMG9 TRA2A NHS SSH2 MTO1 FBXO21 SLC33A1	1.75e-05	1327	164	19	32694731
Pubmed	Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice.	APC DCLK1	2.21e-05	2	164	2	18055444
Pubmed	The SRm160/300 splicing coactivator subunits.	SRRM1 SRRM2	2.21e-05	2	164	2	10668804
Pubmed	Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing.	TRA2B TRA2A	2.21e-05	2	164	2	9546399
Pubmed	Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.	APC DCLK1	2.21e-05	2	164	2	28148261
Pubmed	Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium.	APC2 APC	2.21e-05	2	164	2	27694902
Pubmed	Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.	APC BRCA2	2.21e-05	2	164	2	11215675
Pubmed	DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition.	APC DCLK1	2.21e-05	2	164	2	25211188
Pubmed	Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression.	TRA2B TRA2A	2.21e-05	2	164	2	25970345
Pubmed	APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression.	APC2 APC	2.21e-05	2	164	2	31291912
Pubmed	Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.	APC VASH2	2.21e-05	2	164	2	24885408
Pubmed	Expression of filaggrin-2 protein in the epidermis of human skin diseases: a comparative analysis with filaggrin.	FLG FLG2	2.21e-05	2	164	2	24813994
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	U2SURP THSD7B CUL7 FBXO21 MAST3 PDZD2	3.69e-05	130	164	6	12421765
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SRRM1 NCOA6 KIF23 SFSWAP U2SURP GPATCH4 CEP170 NCOR1 BRCA2 ACIN1 MLLT6 KIF18B SRRM2 MYBL2 NPAT	4.99e-05	954	164	15	36373674
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FLG SRRM1 RAPH1 KDM5A NOC2L U2SURP PNISR CEP128 RYBP NCOR1 C2CD3 CDK13 STARD9 VASH2 ACIN1 ABCC2 TMPRSS7 RIMS2 AGAP2	5.39e-05	1442	164	19	35575683
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	SHROOM3 GBF1 APC RICTOR CUL7 WNK1 CDC42EP1 CEP170 NADK DOCK6	5.52e-05	446	164	10	24255178
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNB4 SHROOM3 KIF23 TRA2B KDM5A APC2 APC DDN GIT2 CEP170 NCOR1 KIAA1217 SSH2 DCLK1 AGAP2	5.54e-05	963	164	15	28671696
Pubmed	USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity.	USP22 APC	6.61e-05	3	164	2	31527800
Pubmed	GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.	FLG FLG2	6.61e-05	3	164	2	28928464
Pubmed	Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in development.	TRA2B TRA2A	6.61e-05	3	164	2	22194695
Pubmed	Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.	TRA2B TRA2A	6.61e-05	3	164	2	23255807
Pubmed	USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer.	USP22 APC	6.61e-05	3	164	2	31801945
Pubmed	Filaggrin and filaggrin 2 processing are linked together through skin aspartic acid protease activation.	FLG FLG2	6.61e-05	3	164	2	32437351
Pubmed	The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.	APC BRCA2	6.61e-05	3	164	2	11466700
Pubmed	POSH is an intracellular signal transducer for the axon outgrowth inhibitor Nogo66.	SHROOM3 MAP3K13	6.61e-05	3	164	2	20926658
Pubmed	Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.	FRG2 FRG2B	6.61e-05	3	164	2	11829491
Pubmed	WNK1 activates ERK5 by an MEKK2/3-dependent mechanism.	WNK1 MAP3K3	6.61e-05	3	164	2	14681216
Pubmed	Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.	FLG FLG2	6.61e-05	3	164	2	23403047
Pubmed	Long-lived intestinal tuft cells serve as colon cancer-initiating cells.	APC DCLK1	6.61e-05	3	164	2	24487592
Pubmed	The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.	NCOR1 MYBL2	6.61e-05	3	164	2	11997503
Pubmed	FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.	FRG2 FRG2B	6.61e-05	3	164	2	15520407
Pubmed	Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.	APC2 APC	6.61e-05	3	164	2	23840886
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	SRRM1 KIF23 TRA2B NOC2L U2SURP FLG2 CCNY TRA2A ACIN1 SSH2 GNAS SRRM2	7.53e-05	660	164	12	32780723
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SRRM1 FAT4 SHROOM3 KIF23 SFSWAP APC EPB41L5 RICTOR GPATCH4 FLG2 CDC42EP1 NCOR1 IQCE	8.71e-05	777	164	13	35844135
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SRRM1 GBF1 SFSWAP KDM5A MRPL55 EPB41L5 FBXO11 GPATCH4 FLG2 CEP170 SCAF1 CDK13 STARD9 PCSK6 TRA2A ACIN1 GNAS FBXO21	8.96e-05	1371	164	18	36244648
Pubmed	Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.	SRRM1 TRA2B POM121C TRA2A TMPRSS7 SRRM2	9.14e-05	153	164	6	28225217
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	SRRM1 KIF23 U2SURP RICTOR PNISR SCAF1 SRRM2 XPOT	9.53e-05	300	164	8	28561026
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	NCOA6 GBF1 GIT2 WNK1 CAMKK2 TMCC2 PPP1R16B	1.02e-04	225	164	7	12168954
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SHROOM3 KIF23 APC RICTOR SRRM2	1.26e-04	102	164	5	15778465
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	RAPH1 THSD7B LRRC27 SSH2 KLHL4	1.26e-04	102	164	5	11214970
Pubmed	The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes.	SRRM1 SRRM2	1.32e-04	4	164	2	10908574
Pubmed	Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal epithelial cells.	PNISR SRRM2	1.32e-04	4	164	2	14578391
Pubmed	Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.	APC BRCA2	1.32e-04	4	164	2	35205366
Pubmed	The SRm160/300 splicing coactivator is required for exon-enhancer function.	SRRM1 TRA2B	1.32e-04	4	164	2	10339552
Pubmed	Brg1 is required to maintain colorectal cancer stem cells.	APC DCLK1	1.32e-04	4	164	2	34415580
Pubmed	Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.	ITGAM FGA	1.32e-04	4	164	2	17932565
Pubmed	Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock.	TRA2B TRA2A	1.32e-04	4	164	2	14765198
Pubmed	Regulated IRE1-dependent mRNA decay sets the threshold for dendritic cell survival.	ERN2 DDIT3	1.32e-04	4	164	2	28459443
Pubmed	Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor.	ITGAM FGA	1.32e-04	4	164	2	22381526
Pubmed	TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway.	TRPC5 CAMKK2	1.32e-04	4	164	2	28600513
Pubmed	A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient βcatenin destruction.	APC2 APC	1.32e-04	4	164	2	26393419
Pubmed	Human transcription factor protein interaction networks.	FLG NCOA6 KIF23 USP22 KDM5A KLF15 GPATCH4 CUL7 FLG2 POM121C RYBP NCOR1 MLLT6 SRRM2 FILIP1L XPOT MYBL2 NPAT	1.50e-04	1429	164	18	35140242
Pubmed	ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes.	SRRM1 TRA2B TRA2A SRRM2 DOCK6	1.58e-04	107	164	5	20508642
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	SRRM1 KIF23 RAPH1 SRRM2 PSRC1	1.65e-04	108	164	5	19531213
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	SRRM1 FAT4 CDC42EP1 TMCC2 SSH2 SRRM2 DCLK1	1.76e-04	246	164	7	15345747
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SFSWAP TRA2B PNISR SCAF1 ZRSR2P1 TRA2A ACIN1	1.99e-04	251	164	7	31076518
Pubmed	Angulin proteins ILDR1 and ILDR2 regulate alternative pre-mRNA splicing through binding to splicing factors TRA2A, TRA2B, or SRSF1.	TRA2B TRA2A	2.19e-04	5	164	2	28785060
Pubmed	Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates.	FLG PCSK6	2.19e-04	5	164	2	11380615
Pubmed	Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.	ILK ITGAM	2.19e-04	5	164	2	22677557
Pubmed	Restoration of Replication Fork Stability in BRCA1- and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers.	ZRANB3 BRCA2	2.19e-04	5	164	2	29053959
Pubmed	Dclk1 distinguishes between tumor and normal stem cells in the intestine.	APC DCLK1	2.19e-04	5	164	2	23202126
Pubmed	Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.	ITGAM FGA	2.19e-04	5	164	2	30737131
Pubmed	Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes.	SRRM1 TRA2B U2SURP ACIN1 SRRM2	2.22e-04	115	164	5	17332742
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SRRM1 CACNB4 APC CAMKK2 RIMS2 SRRM2 DCLK1 AGAP2	2.57e-04	347	164	8	17114649
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SHROOM3 SFSWAP PCNX3 NET1 KDM5A NOC2L ZNF652 APC EPB41L5 FBXO11 RICTOR GPATCH4 PNISR ORC1 SCAF1 CDK13 LSM11 DCLK1	2.64e-04	1497	164	18	31527615
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	SRRM1 TRA2B U2SURP EPB41L5 GPATCH4 POM121C CDK13 ACIN1 GNAS SRRM2 FBXO21	2.97e-04	655	164	11	35819319
Pubmed	Genomic analysis of mouse retinal development.	PITPNM2 MAK ILK USP22 PCNX3 NOC2L APC PNISR DDIT3 NCOR1 MCM9 TRA2A ACIN1 DCLK1	3.14e-04	1006	164	14	15226823
Pubmed	An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma.	KIF23 MYBL2	3.27e-04	6	164	2	27212033
Pubmed	BRCT domains of the DNA damage checkpoint proteins TOPBP1/Rad4 display distinct specificities for phosphopeptide ligands.	TICRR RHNO1	3.27e-04	6	164	2	30295604
Pubmed	Expression of Cornified Envelope Proteins in Skin and Its Relationship with Atopic Dermatitis Phenotype.	FLG FLG2	3.27e-04	6	164	2	27304082
Pubmed	Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas.	APC BRF1	3.27e-04	6	164	2	30858608
Pubmed	Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.	ILK RICTOR	3.27e-04	6	164	2	18339839
Pubmed	The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.	APC2 APC	3.27e-04	6	164	2	10074433
Pubmed	A coactivator of pre-mRNA splicing.	SRRM1 SRRM2	3.27e-04	6	164	2	9531537
Pubmed	The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways.	APC GNAS	3.27e-04	6	164	2	20531296
Pubmed	Lineage tracing and targeting of IL17RB+ tuft cell-like human colorectal cancer stem cells.	APC DCLK1	3.27e-04	6	164	2	31182574
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	NET1 CYBC1 FBXO11 WNK1 ZRSR2P1 TIMM17A NHS XPOT	3.47e-04	363	164	8	14691545
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	TRA2B NOC2L FBXO11 WNK1 PLEKHH3 C2CD3 TRA2A LSM11 MTO1	3.68e-04	462	164	9	31138677
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	PITPNM2 DDN CAMKK2 GNAS RIMS2 DCLK1 AGAP2	3.95e-04	281	164	7	28706196
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	FLG GBF1 ILK APC PLEKHH3 NCOR1 GARIN3 MLLT6 SSH2 MTO1 RAD17	4.54e-04	689	164	11	36543142
Interaction	YWHAH interactions	PRKD2 SRRM1 TICRR NCOA6 SHROOM3 KIF23 GBF1 USP22 SFSWAP NET1 KDM5A EXPH5 APC EPB41L5 KLF15 RICTOR GIT2 WNK1 CEP128 MAP3K3 CCNY CDC42EP1 CEP170 LNP1 C2CD3 MAST4 KCNQ5 STARD9 KIAA1217 VASH2 NADK NHS SSH2 RIMS2 SRRM2 DOCK6 DCLK1 MAST3	1.05e-14	1102	161	38	int:YWHAH
Interaction	YWHAG interactions	SRRM1 TICRR NCOA6 SHROOM3 KIF23 GBF1 USP22 TRA2B RAPH1 NET1 EXPH5 APC EPB41L5 RICTOR GIT2 CUL7 WNK1 MAP3K3 CCNY CDC42EP1 CEP170 LNP1 C2CD3 MAST4 KCNQ5 STARD9 UCP3 VASH2 NADK TRA2A ACIN1 NHS SSH2 GNAS SRRM2 DCLK1 MAST3	2.46e-12	1248	161	37	int:YWHAG
Interaction	YWHAB interactions	TICRR SHROOM3 KIF23 GBF1 EXPH5 APC EPB41L5 RICTOR CUL7 WNK1 MAP3K3 CCNY CDC42EP1 CEP170 LNP1 MAST4 KCNQ5 STARD9 UCP3 VASH2 NADK NHS SSH2 SRRM2 DCLK1 MAST3 AGAP2	3.40e-08	1014	161	27	int:YWHAB
Interaction	YWHAQ interactions	PRKD2 TICRR NCOA6 SHROOM3 KIF23 GBF1 USP22 TRIM42 EXPH5 APC EPB41L5 RICTOR CUL7 WNK1 MAP3K3 CDC42EP1 CEP170 LNP1 MAST4 KCNQ5 STARD9 UCP3 VASH2 FGA NADK NHS SSH2 DCLK1	6.65e-08	1118	161	28	int:YWHAQ
Interaction	NUP43 interactions	SRRM1 NCOA6 TRA2B KDM5A NOC2L APC RICTOR GPATCH4 CUL7 POM121C SCAF1 NCOR1 BRCA2 ACIN1 MLLT6 SRRM2 MYBL2 PDZD2 NPAT	6.36e-07	625	161	19	int:NUP43
Interaction	YWHAZ interactions	PRKD2 TICRR SHROOM3 KIF23 GBF1 TRA2B RAPH1 EXPH5 APC RICTOR CUL7 WNK1 MAP3K3 CCNY CDC42EP1 CEP170 LNP1 NCOR1 MAST4 KCNQ5 STARD9 UCP3 NADK NHS SSH2 DCLK1 MAST3	5.76e-06	1319	161	27	int:YWHAZ
Interaction	YWHAE interactions	TICRR SHROOM3 KIF23 GBF1 TRA2B EXPH5 APC RICTOR GIT2 CUL7 WNK1 MAP3K3 CCNY CDC42EP1 CEP170 LNP1 MAST4 KCNQ5 CDK13 NADK NHS SSH2 RIMS2 SRRM2 DCLK1 MAST3	7.21e-06	1256	161	26	int:YWHAE
Interaction	SFN interactions	NCOA6 SHROOM3 KIF23 GBF1 EXPH5 APC EPB41L5 RICTOR WNK1 CDC42EP1 CEP170 CAMKK2 MAST4 KCNQ5 NADK NHS SSH2 SRRM2	1.11e-05	692	161	18	int:SFN
Interaction	FLG interactions	FLG KIF23 MAK RICTOR FLG2 PCSK6 MLLT6	2.43e-05	107	161	7	int:FLG
Interaction	UBXN6 interactions	PRKD2 NOC2L RICTOR GIT2 ODAD2 CUL7 PLEKHH3 CDC42EP1 CAMKK2 KIF18B RAD17	6.30e-05	325	161	11	int:UBXN6
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	TRA2B TRIM42 NOC2L TRPC5 APC WNK1 NCOR1 PPP1R16B	6.81e-06	181	99	8	694
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K3 MAP3K13 MAP3K19	2.96e-04	24	99	3	654
GeneFamily	ADAMTS like	THSD4 ADAMTSL2	6.12e-04	7	99	2	947
GeneFamily	EF-hand domain containing\|S100 fused type protein family	FLG FLG2	6.12e-04	7	99	2	1350
GeneFamily	PDZ domain containing	SHROOM3 MAST4 RIMS2 MAST3 PDZD2	1.49e-03	152	99	5	1220
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	APC2 APC ODAD2	1.68e-03	43	99	3	409
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF23 STARD9 KIF18B	2.04e-03	46	99	3	622
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	ANK1 TRA2B PNISR PARP10 NCOR1 FMN1 PPP1R16B ACIN1 NHS ASTN2 MAP3K13 ABCC2 RIMS2 SRRM2 PDZD2	5.81e-08	417	163	15	M39224
Coexpression	GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	KIF23 RAPH1 APC HEATR5A DDIT3 ZRANB3 STARD9 TMCC2 SSH2	4.76e-06	200	163	9	M8632
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	THSD4 GBF1 ILK TRA2B RAPH1 OLFML2B GIT2 WNK1 CEP128 CCNY CHST8 BRCA2 KIAA1217 PCSK6 VASH2 ASTN2 SSH2 GNAS FBXO21 DCLK1	4.95e-06	1009	163	20	M157
Coexpression	GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP	DDN ORC1 BRCA2 ASTN2 ABCC2 SLC33A1 ADAMTSL2 IQCE	2.93e-05	193	163	8	M8394
Coexpression	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	NCOA6 ILK USP22 KDM5A RICTOR GIT2 NCOR1 MAST3	3.78e-05	200	163	8	M5851
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 CACNB4 SHROOM3 EXPH5 EPB41L5 MAST4 FMN1 KIAA1217 MAP3K13 PDZD2	3.71e-09	199	164	10	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 SHROOM3 EXPH5 EPB41L5 MAST4 FMN1 KIAA1217 MAP3K13 PDZD2	5.66e-08	199	164	9	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT4 SHROOM3 CD244 LNP1 SAMD10 TMTC4 PPP1R16B C19orf44	1.46e-07	160	164	8	60fa1c717410aad7e8647703cb416cd7617cac29
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRA2B FBXO11 RICTOR PNISR TRA2A NHS GNAS FILIP1L	4.81e-07	187	164	8	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	THSD4 SHROOM3 EXPH5 EPB41L5 MAST4 KIAA1217 MAP3K13 PDZD2	5.01e-07	188	164	8	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TICRR KIF23 ANK1 CEP128 ORC1 KCNQ5 BRCA2 KIF18B	5.65e-07	191	164	8	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 EXPH5 EPB41L5 MAST4 NECAB1 KIAA1217 MAP3K13 PDZD2	5.65e-07	191	164	8	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	THSD4 SHROOM3 EXPH5 EPB41L5 MAST4 KIAA1217 MAP3K13 PDZD2	5.88e-07	192	164	8	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	TICRR KIF23 ANK1 CEP128 KCNQ5 BRCA2 KIF18B MYBL2	6.61e-07	195	164	8	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 SHROOM3 EXPH5 EPB41L5 MAST4 NECAB1 MAP3K13 PDZD2	7.70e-07	199	164	8	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 CACNB4 SHROOM3 EPB41L5 NECAB1 FMN1 MAP3K13 PDZD2	7.70e-07	199	164	8	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TICRR KIF23 ZRANB3 ORC1 KIF18B PSRC1 MYBL2	2.69e-06	165	164	7	96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564
ToppCell	Dividing_Macrophages-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	TICRR KIF23 ORC1 BRCA2 KIF18B PSRC1 MYBL2	4.45e-06	178	164	7	1893fadac2ec3d5de0a641e57b7b2f962012a9ba
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TICRR KIF23 CEP128 BRCA2 KIF18B PSRC1 MYBL2	4.78e-06	180	164	7	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	TICRR KIF23 ORC1 BRCA2 KIF18B PSRC1 MYBL2	5.33e-06	183	164	7	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR KIF23 CEP128 BRCA2 KIF18B PSRC1 MYBL2	5.73e-06	185	164	7	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RAPH1 EXPH5 GRAMD1A FMN1 PPP1R16B NHS FGF9	6.15e-06	187	164	7	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	THSD4 SHROOM3 EXPH5 EPB41L5 MAST4 MAP3K13 PDZD2	6.36e-06	188	164	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TICRR KIF23 CEP128 BRCA2 KIF18B PSRC1 MYBL2	6.59e-06	189	164	7	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 NET1 EPB41L5 MAST4 NECAB1 FMN1 KIAA1217	6.82e-06	190	164	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KIF23 MAK CEP128 BRCA2 PCSK6 CCDC157 TMEM200C	6.82e-06	190	164	7	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TICRR CEP128 BRCA2 NHS KIF18B ADAMTSL2 MYBL2	6.82e-06	190	164	7	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	SHROOM3 EXPH5 EPB41L5 MAST4 KIAA1217 MAP3K13 PDZD2	7.30e-06	192	164	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Dividing_Macrophages-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	TICRR KIF23 ITGAM ORC1 KIF18B PSRC1 MYBL2	7.30e-06	192	164	7	741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TICRR ORC1 BRCA2 NHS KIF18B ADAMTSL2 MYBL2	7.55e-06	193	164	7	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TICRR KIF23 CEP128 BRCA2 NHS ADAMTSL2 MYBL2	7.55e-06	193	164	7	516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TICRR KIF23 PDE4C ORC1 BRCA2 KIF18B MYBL2	7.55e-06	193	164	7	e45ce9cf8421512b57f157c24b64793b47b4ba4b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TICRR CEP128 ORC1 BRCA2 NHS ADAMTSL2 MYBL2	7.81e-06	194	164	7	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLG INSYN1 OLFML2B DDN NECAB1 FGA TMEM200C	7.81e-06	194	164	7	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TICRR KIF23 CEP128 BRCA2 KIF18B PSRC1 MYBL2	8.08e-06	195	164	7	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TICRR KIF23 CEP128 ORC1 BRCA2 KIF18B MYBL2	8.08e-06	195	164	7	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	COVID-19_Severe-PLT_4\|World / Disease Group and Platelet Clusters	SRRM1 TRA2B NET1 DDIT3 RYBP TRA2A NPAT	8.35e-06	196	164	7	ad43efdd4d73b6615f65f06a315b33576e317473
ToppCell	COVID-19_Severe-PLT_4\|COVID-19_Severe / Disease Group and Platelet Clusters	SRRM1 TRA2B NET1 DDIT3 RYBP TRA2A NPAT	8.92e-06	198	164	7	abfddbee99ef8c7719e6e6f62571e9be030e4acf
ToppCell	distal-Hematologic-Proliferating_Macrophage-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TICRR KIF23 ORC1 BRCA2 KIF18B PSRC1 MYBL2	8.92e-06	198	164	7	2b0716e900bce54ad1825d6dcdaf4ebf31f355c4
ToppCell	MNPs-Dividing_Macrophages\|MNPs / lung cells shred on cell class, cell subclass, sample id	TICRR KIF23 ORC1 BRCA2 KIF18B PSRC1 MYBL2	9.22e-06	199	164	7	5952980d0ece5d73f3e9f340c56a38b34d2f2309
ToppCell	Dividing_Macrophages\|World / lung cells shred on cell class, cell subclass, sample id	TICRR KIF23 ORC1 BRCA2 KIF18B PSRC1 MYBL2	9.22e-06	199	164	7	5c755b6876e164dc847ef7c723f850f227cf3a87
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 OLFML2B CCNY CDC42EP1 CAMKK2 KIAA1217 ADAMTSL2	9.53e-06	200	164	7	bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	TICRR KIF23 CEP128 BRCA2 KIF18B PSRC1 MYBL2	9.53e-06	200	164	7	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	PITPNM2 PRKD2 FAT4 MAST4 KIAA1217 DOCK6 KLHL4	9.53e-06	200	164	7	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	Biopsy_Control_(H.)-Immune-Proliferating_Macrophages\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	TICRR KIF23 ORC1 BRCA2 KIF18B PSRC1 MYBL2	9.53e-06	200	164	7	ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e
ToppCell	PSB-critical-LOC-Lymphoid-Treg\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TICRR KIF23 ORC1 BRCA2 KIF18B PSRC1 MYBL2	9.53e-06	200	164	7	3e3de496508efb2f95e5e8684f97687381e96493
ToppCell	NS-critical-d_07-13-Lymphoid-NKT-proliferating\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TICRR KIF23 ORC1 BRCA2 KIF18B PSRC1 MYBL2	9.53e-06	200	164	7	7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TICRR KIF23 CEP128 BRCA2 KIF18B PSRC1 MYBL2	9.53e-06	200	164	7	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 CACNB4 SHROOM3 ERN2 FMN1 KIAA1217 MAP3K13	9.53e-06	200	164	7	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	(24)_B_cell_cycling\|World / shred on Cell_type and subtype	THSD4 KIF23 NET1 ORC1 KIF18B PSRC1 MYBL2	1.02e-05	202	164	7	a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	MAK TRPC5 DDN CHST8 KIAA1549L TMPRSS7	1.51e-05	143	164	6	5fb5a4ea93e5cce55d427e3b4a50a979504fad3c
ToppCell	343B-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	THSD4 SRRM5 NET1 ZNF652 LNP1 KLB	2.30e-05	154	164	6	71d33b5dbfab5820e3daddb01806a69116ba8008
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD244 HEATR5A CAMTA2 CCDC88B KIAA1549L SSH2	2.57e-05	157	164	6	8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD244 HEATR5A CAMTA2 CCDC88B KIAA1549L SSH2	2.57e-05	157	164	6	ee1be3c756b72fceac6b4ccb416dd4bd031a2193
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD244 HEATR5A CAMTA2 CCDC88B KIAA1549L SSH2	2.57e-05	157	164	6	008f938a338f43c3251dcac574f1b4f689926c71
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	INSYN1 KLF15 NALCN NECAB1 FGF9 TMEM200C	2.76e-05	159	164	6	fd7db2f7328cfefdc3ada2af91006d5a91d137e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	INSYN1 KLF15 NALCN NECAB1 FGF9 TMEM200C	2.76e-05	159	164	6	aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	INSYN1 KLF15 NALCN NECAB1 FGF9 TMEM200C	2.76e-05	159	164	6	8bbdef1e927f3130b578d7d7c5ff38bbe06fab63
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Pre-B\|bone_marrow / Manually curated celltypes from each tissue	PITPNM2 PDE4C SPATA6 CEP128 TMTC4 PGBD2	3.06e-05	162	164	6	e088e66aabc307dde5d2b9aa295c34ef68155b1a
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	THSD7B ERN2 GJD4 CHST8 KCNQ5 DCLK1	3.17e-05	163	164	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	10x5'-Liver-Hematopoietic_progenitors\|Liver / Manually curated celltypes from each tissue	TICRR RAPH1 BRCA2 NHS KIF18B MYBL2	3.51e-05	166	164	6	ae967570248cf86ca3ddf55e33bcbb3e4e3684bc
ToppCell	10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Liver / Manually curated celltypes from each tissue	TICRR RAPH1 BRCA2 NHS KIF18B MYBL2	3.51e-05	166	164	6	a176e87aa6eec81d1fb79a028f759182d11b567d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR CEP128 ORC1 BRCA2 KIF18B MYBL2	3.63e-05	167	164	6	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR CD244 ITGAM SSH2 CORO7 AGAP2	3.88e-05	169	164	6	b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR CD244 ITGAM SSH2 CORO7 AGAP2	3.88e-05	169	164	6	83d1bcf33872b01ea9614f608a3e4ab30df25c7e
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAND2 INSRR SCAF1 MAST4 NECAB1 XPOT	4.56e-05	174	164	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 CAND2 C2CD3 CCDC157 MAST3 AGAP2	4.71e-05	175	164	6	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE4C EXPH5 CAMKK2 NECAB1 MAST3 PDZD2	4.86e-05	176	164	6	07abf29d681abdd6c7cc87f9eaf9377e92ce212c
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	OLFML2B BRCA2 KIF18B RHNO1 PSRC1 MYBL2	4.86e-05	176	164	6	4bba41ebf9dd187c8705a6997ed039878de62b4e
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNB4 SHROOM3 PDE4C EPB41L5 SAMD10 DOCK6	5.02e-05	177	164	6	a235ff4f37a7622216526191efc4832fb8ed6957
ToppCell	NS-moderate-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KIF23 ORC1 KIAA1549L KIF18B PSRC1 MYBL2	5.02e-05	177	164	6	174c54acfe19e2bb31418d69e228032ba724cbb6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE4C EXPH5 CAMKK2 NECAB1 MAST3 PDZD2	5.18e-05	178	164	6	5d6297f34e104bacefb25c4e2338b50fe13dd19a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR CEP128 ORC1 BRCA2 KIF18B MYBL2	5.34e-05	179	164	6	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ODAD2 CHST8 KCNQ5 TMTC4 FMN1 TMEM200C	5.51e-05	180	164	6	b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ODAD2 CHST8 KCNQ5 TMTC4 FMN1 TMEM200C	5.51e-05	180	164	6	f96c5be4705e3d338c0393d2885ac8d5beccd6fd
ToppCell	Endothelial-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	PRKD2 CHST8 SAMD10 STARD9 MAP3K19 KLHL4	5.68e-05	181	164	6	4fe0215d08f03d4e24749d70fce01b7aa22906fd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR KIF23 CEP128 BRCA2 KIF18B PSRC1	5.86e-05	182	164	6	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 EPB41L5 DDN NALCN NECAB1 TMEM200C	6.04e-05	183	164	6	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 EPB41L5 DDN NALCN NECAB1 TMEM200C	6.04e-05	183	164	6	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	Dividing_Macrophages-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	TICRR KIF23 BRCA2 KIF18B PSRC1 MYBL2	6.22e-05	184	164	6	f15ce786d25c6546804a6d1efcc2ad645f2ef54e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	PITPNM2 SHROOM3 EPB41L5 MAST4 KIAA1217 MAP3K13	6.41e-05	185	164	6	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	TICRR KIF23 KCNQ5 BRCA2 KIF18B MYBL2	6.41e-05	185	164	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	PDE4C RAPH1 THSD7B DOCK6 AGAP2 PDZD2	6.41e-05	185	164	6	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	Dividing_Macrophages-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	TICRR KIF23 ORC1 KIF18B PSRC1 MYBL2	6.61e-05	186	164	6	0067eb78d4c7e32b9563550d9fcaf13445ee6a48
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	SHROOM3 PDE4C EXPH5 EPB41L5 MAST4 KIAA1217	6.61e-05	186	164	6	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR CEP128 BRCA2 KIF18B PSRC1 MYBL2	6.80e-05	187	164	6	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative\|Multiple_Sclerosis / Disease, Lineage and Cell Type	TICRR KIF23 ORC1 BRCA2 KIF18B MYBL2	7.01e-05	188	164	6	6c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	EXPH5 CEP128 KIAA1217 PPP1R16B NHS FGF9	7.01e-05	188	164	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	SHROOM3 EXPH5 EPB41L5 ERN2 MAST4 KIAA1217	7.22e-05	189	164	6	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMKK2 KCNQ5 NECAB1 FMN1 DCLK1 MAST3	7.22e-05	189	164	6	c3df0e3c50af8f1cfb4d790e668bd7f42b276992
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMKK2 KIAA1549L KCNQ5 NECAB1 DCLK1 MAST3	7.43e-05	190	164	6	d594da827e3c16644952b9589cc12b947ce36279
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	THSD4 PITPNM2 FAT4 STARD9 KIAA1217 DOCK6	7.43e-05	190	164	6	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMKK2 KIAA1549L KCNQ5 NECAB1 DCLK1 MAST3	7.43e-05	190	164	6	49e09cdb843b3d889a06a811aa5affae68b25a75
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TICRR KIF23 CEP128 BRCA2 KIF18B MYBL2	7.43e-05	190	164	6	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T\|GI_small-bowel / Manually curated celltypes from each tissue	TICRR KIF23 BRCA2 KIF18B PSRC1 MYBL2	7.65e-05	191	164	6	e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB4 SHROOM3 MAST4 NECAB1 MAP3K13 PDZD2	7.65e-05	191	164	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 EPB41L5 MAST4 KIAA1217 MAP3K13 PDZD2	7.65e-05	191	164	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TICRR KIF23 ORC1 BRCA2 KIF18B MYBL2	7.65e-05	191	164	6	b85a0978dc1e8af4f49423f56dcfd52efce09ed1
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	SHROOM3 EXPH5 EPB41L5 MAST4 KIAA1217 NHS	7.87e-05	192	164	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	CACNB4 SHROOM3 MAST4 NECAB1 MAP3K13 PDZD2	7.87e-05	192	164	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMKK2 KIAA1549L KCNQ5 NECAB1 DCLK1 MAST3	7.87e-05	192	164	6	5c7e8b80b44d9ce55c797cdf8267ac5382e26cac
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 FAT4 KIAA1217 PCSK6 PPP1R16B DOCK6	8.10e-05	193	164	6	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 FAT4 MAST4 KIAA1217 PPP1R16B DOCK6	8.10e-05	193	164	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	TICRR KIF23 BRCA2 KIF18B PSRC1 MYBL2	8.10e-05	193	164	6	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	THSD4 OLFML2B KCNQ5 NECAB1 NHS ADAMTSL2	8.10e-05	193	164	6	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	KDM5A ZNF652 EPB41L5 GIT2 CUL7 WNK1 BRF1 MAST4 NADK DOCK6 IQCE	2.00e-07	197	164	11	5453_DN
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	KDM5A ZNF652 APC CAMTA2 WNK1 CDC42EP1 BRF1 CDK13 VASH2 ZNF324	1.73e-06	197	164	10	2307_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A	FAT4 MAK GBF1 CUL7 ERN2 MAST4 PCSK6 GNAS SRRM2 AGAP2	1.90e-06	199	164	10	4995_UP
Drug	Ethamivan [304-84-7]; Down 200; 18uM; PC3; HT_HG-U133A	KDM5A ZNF652 GIT2 NCOR1 MAST4 TMCC2 VASH2 ZNF324 MAST3	1.19e-05	194	164	9	7260_DN
Drug	Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	TRPC5 FBXO11 CUL7 DDIT3 CDC42EP1 TRA2A IQCE AGAP2 FILIP1L	1.19e-05	194	164	9	7032_UP
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A	PRKD2 TRA2B ZNF652 ERN2 ZC3H3 MAP3K3 BRF1 NADK ZNF324	1.35e-05	197	164	9	3549_DN
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A	PDE4C OLFML2B TRPC5 FRS3 DDN ERN2 CDK13 ABCC2 KLHL4	1.41e-05	198	164	9	6622_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; PC3; HT_HG-U133A	SPATA6 APC WNK1 CHST8 CDK13 MAP3K13 ABCC2 FILIP1L KLHL4	1.52e-05	200	164	9	4006_UP
Drug	Thyronines	SHBG UCP3	5.16e-05	2	164	2	ctd:D013970
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; HL60; HT_HG-U133A	ERN2 ITGAM WNK1 NCOR1 CAMKK2 NADK FBXO21 IQCE	7.04e-05	189	164	8	2928_DN
Drug	Methotrexate [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A	U2SURP APC ERN2 WNK1 MCM9 SMG9 PSRC1 IQCE	7.31e-05	190	164	8	6318_DN
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	PDE4C GBF1 ZNF652 ERN2 WNK1 CDK13 TRA2A GNAS	7.86e-05	192	164	8	3729_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A	KDM5A APC EPB41L5 GIT2 WNK1 DDIT3 GNAS AGAP2	7.86e-05	192	164	8	3400_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	CUL7 ERN2 WNK1 ZC3H3 MAST4 CDK13 SRRM2 DOCK6	8.15e-05	193	164	8	4322_UP
Drug	Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ZNF652 EPB41L5 GIT2 ERN2 WNK1 DDIT3 NADK AGAP2	8.45e-05	194	164	8	2637_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	KIF23 U2SURP APC PNISR ZC3H3 PCSK6 NADK FBXO21	8.45e-05	194	164	8	2504_DN
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A	THSD4 FAT4 GIT2 CUL7 ZNF324 ASTN2 FBXO21 IQCE	8.76e-05	195	164	8	7377_UP
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	KIF23 NCOR1 MAST4 BRCA2 ZNF324 ACIN1 GNAS SRRM2	9.08e-05	196	164	8	2056_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; PC3; HT_HG-U133A	PDE4C OLFML2B TRPC5 DDN CUL7 CDK13 ASTN2 KLHL4	9.08e-05	196	164	8	6631_DN
Drug	Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A	APC CUL7 ERN2 WNK1 PNISR KIAA1549L VASH2 ASTN2	9.08e-05	196	164	8	3699_DN
Drug	Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A	APC CAMTA2 GIT2 ERN2 CHST8 BRCA2 PCSK6 ZNF324	9.08e-05	196	164	8	4802_DN
Drug	Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A	APC CUL7 WNK1 DDIT3 CDK13 PCSK6 NADK TRA2A	9.41e-05	197	164	8	4832_UP
Drug	radicicol; Up 200; 0.1uM; PC3; HG-U133A	ANK1 SFSWAP U2SURP EPB41L5 NADK ZNF324 SRRM2 PDZD2	9.41e-05	197	164	8	484_UP
Drug	Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	APC CUL7 ERN2 MAST4 CDK13 PCSK6 ASTN2 IQCE	9.41e-05	197	164	8	6776_DN
Drug	Tyloxapol [25301-02-4]; Down 200; 4uM; MCF7; HT_HG-U133A	PRKD2 KDM5A FBXO11 GIT2 ZNF324 TIMM17A ASTN2 FILIP1L	9.41e-05	197	164	8	5672_DN
Drug	Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	FRS3 GIT2 ERN2 CHST8 MAST4 SRRM2 MAST3 IQCE	9.74e-05	198	164	8	5786_DN
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A	CACNB4 EXPH5 FBXO11 GIT2 CUL7 ERN2 VASH2 AGAP2	9.74e-05	198	164	8	7544_UP
Drug	Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	GIT2 ERN2 MAST4 ZNF324 ASTN2 DOCK6 MAST3 IQCE	9.74e-05	198	164	8	1538_DN
Drug	Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A	GBF1 KDM5A APC ERN2 CHST8 ABCC2 DOCK6 FILIP1L	9.74e-05	198	164	8	5361_UP
Drug	Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	KDM5A EXPH5 EPB41L5 ZC3H3 ZNF324 ABCC2 SRRM2 DOCK6	9.74e-05	198	164	8	7200_DN
Drug	Isocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A	THSD4 PDE4C KDM5A ZNF652 GIT2 WNK1 BRF1 RIMS2	9.74e-05	198	164	8	4706_UP
Drug	C75; Up 200; 10uM; PC3; HT_HG-U133A	CAMTA2 WNK1 CHST8 NADK DOCK6 SLC33A1 IQCE NPAT	9.74e-05	198	164	8	6428_UP
Drug	Benzbromarone [3562-84-3]; Down 200; 9.4uM; HL60; HT_HG-U133A	GBF1 KDM5A WNK1 ZC3H3 PPP1R16B NADK SRRM2 FBXO21	9.74e-05	198	164	8	1291_DN
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	APC FBXO11 ERN2 BRF1 NADK ZNF324 MAST3 FILIP1L	9.74e-05	198	164	8	5262_DN
Drug	Diflunisal [22494-42-4]; Up 200; 16uM; MCF7; HT_HG-U133A	PDE4C EXPH5 OLFML2B CHST8 NADK ZNF324 RIMS2 FBXO21	9.74e-05	198	164	8	1490_UP
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; PC3; HT_HG-U133A	TRPC5 FRS3 APC CHST8 BRF1 BRCA2 SRRM2 FILIP1L	1.01e-04	199	164	8	4635_DN
Drug	Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A	APC CDK13 PCSK6 TMCC2 UCP3 FGA RIMS2 MAP3K19	1.01e-04	199	164	8	3200_UP
Drug	Anabasine [494-52-0]; Down 200; 24.6uM; MCF7; HT_HG-U133A	MAST4 PCSK6 TMCC2 VASH2 TRA2A GNAS RIMS2 FBXO21	1.01e-04	199	164	8	6074_DN
Drug	Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A	KDM5A WNK1 PCSK6 TMCC2 NADK RIMS2 FBXO21 FILIP1L	1.01e-04	199	164	8	6086_DN
Drug	Boldine [476-70-0]; Up 200; 12.2uM; HL60; HT_HG-U133A	TRPC5 FRS3 CUL7 ERN2 CAMKK2 TMCC2 FGF9 DOCK6	1.04e-04	200	164	8	2148_UP
Disease	PEELING SKIN SYNDROME 3	FLG2 CHST8	2.74e-05	2	155	2	C4015729
Disease	familial adenomatous polyposis 1 (implicated_via_orthology)	APC2 APC	2.74e-05	2	155	2	DOID:0080409 (implicated_via_orthology)
Disease	PEELING SKIN SYNDROME 6	FLG2 CHST8	2.74e-05	2	155	2	C4748093
Disease	Colorectal Carcinoma	APC2 APC WNK1 DDIT3 GJD4 CHST8 BRF1 KCNQ5 ACIN1 GNAS ABCC2 SLC33A1 DCLK1	9.09e-05	702	155	13	C0009402
Disease	cholangiocarcinoma (is_implicated_in)	APC GNAS ABCC2	2.03e-04	22	155	3	DOID:4947 (is_implicated_in)
Disease	red blood cell density measurement	THSD4 SRRM1 SHROOM3 ANK1 EPB41L5 RICTOR WNK1 RYBP BRF1 FMN1 PCSK6 SSH2 FBXO21 PGBD2	2.37e-04	880	155	14	EFO_0007978
Disease	peeling skin syndrome (is_implicated_in)	FLG2 CHST8	4.06e-04	6	155	2	DOID:0060283 (is_implicated_in)
Disease	colorectal cancer (implicated_via_orthology)	APC2 APC BRF1	5.20e-04	30	155	3	DOID:9256 (implicated_via_orthology)
Disease	endometrial cancer (is_implicated_in)	SHBG APC BRCA2	8.94e-04	36	155	3	DOID:1380 (is_implicated_in)
Disease	white matter microstructure measurement	RAPH1 SCAF1 PARP10 MAST4 TMCC2 MAP3K13 SSH2 CCDC157	1.11e-03	390	155	8	EFO_0005674
Disease	medulloblastoma (is_implicated_in)	APC BRCA2	1.20e-03	10	155	2	DOID:0050902 (is_implicated_in)
Disease	Pseudohypoaldosteronism, Type I	WNK1 GNAS	1.20e-03	10	155	2	C0268436
Disease	Pseudohypoaldosteronism	WNK1 GNAS	1.20e-03	10	155	2	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	WNK1 GNAS	1.20e-03	10	155	2	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	WNK1 GNAS	1.20e-03	10	155	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	WNK1 GNAS	1.20e-03	10	155	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	WNK1 GNAS	1.20e-03	10	155	2	C1449842
Disease	Neoplasm of uncertain or unknown behavior of breast	NCOR1 BRCA2 MAP3K13	1.31e-03	41	155	3	C0496956
Disease	Breast adenocarcinoma	NCOR1 BRCA2 MAP3K13	1.31e-03	41	155	3	C0858252
Disease	Malignant neoplasm of breast	NCOA6 ANK1 RAPH1 NET1 APC2 WNK1 DDIT3 NCOR1 TMTC4 BRCA2 NHS ASTN2 MAP3K13 AGAP2	1.64e-03	1074	155	14	C0006142
Disease	RS-10-hydroxywarfarin measurement	ZNF441 NALCN NECAB1 DOCK6	1.80e-03	98	155	4	EFO_0803330
Disease	Benign tumor of pancreas	APC BRCA2	2.06e-03	13	155	2	C0347284
Disease	gallbladder cancer (is_implicated_in)	APC RICTOR	2.06e-03	13	155	2	DOID:3121 (is_implicated_in)
Disease	CD209 antigen measurement	PSRC1 ADAMTSL2	2.39e-03	14	155	2	EFO_0008077
Disease	hematocrit	SRRM1 SHROOM3 RAPH1 PELI3 EPB41L5 KLF15 RYBP FMN1 SMG9 SSH2 FBXO21 CCDC157 MAP3K19	2.70e-03	1011	155	13	EFO_0004348
Disease	glucuronate measurement	EPB41L5 DCLK1	3.97e-03	18	155	2	EFO_0010486
Disease	Pancreatic carcinoma	APC BRCA2	4.42e-03	19	155	2	C0235974
Disease	optic disc size measurement	CDC42EP1 KCNQ5 DCLK1 FILIP1L PDZD2	4.65e-03	205	155	5	EFO_0004832
Disease	uric acid measurement	PRKD2 FAT4 SHROOM3 PCNX3 INSRR KLF15 FMN1 GNAS KLB	5.09e-03	610	155	9	EFO_0004761

Protein segments in the cluster

Peptide	Gene	Start	Entry
SRSHSPLRSKQRDVA	ACIN1	601	Q9UKV3
SHKDSSRQRRPGNFS	SLC33A1	6	O00400
VFRHKDSRGKSPSRR	ALKBH2	196	Q6NS38
KSTAAASSRQSRPRV	GNAS	186	P84996
GSNRNSPKHTRLRTS	CEP170	1246	Q5SW79
RRSRSASPSTQQEKH	MLLT6	216	P55198
RRQHSTGRKPHCGTR	LINC00242	126	Q5T6M2
AARSTHRGTRSLPTV	CEP128	21	Q6ZU80
KAGRRSSLQSPASVA	CCDC88B	591	A6NC98
SGRQSRNLKPDRRHT	ANK1	1486	P16157
RRSKSPQAMASHGSR	FAT4	4751	Q6V0I7
TPREGTRTKRHQKFT	FGF9	171	P31371
HRTSATLPARNKGSF	CAMTA2	1146	O94983
PGSLHRAAKRRTSLF	AGAP2	636	Q99490
SNHSSLKRRPSARGS	GIT2	496	Q14161
SSPKLRRNAHSRLES	CCNY	11	Q8ND76
ADSSRHSGIPRRQAS	FLG	1041	P20930
KATRRAHTLPRSSQG	DDN	431	O94850
RKRLSPGRGQASSAH	CCDC157	731	Q569K6
HSPTSQVARGTTTRR	CACNB4	16	O00305
PVSHRASQSLRSRKS	CDK13	326	Q14004
RRRIPQKSASTEATH	ASTN2	236	O75129
SRRGHVTPNLSRASS	GRAMD1A	271	Q96CP6
RTLQRKSITRHGSLS	RAPH1	1171	Q70E73
SHRRKNGPSTLESSR	RAD17	46	O75943
RSTHGNKKPRRSSGR	FMN1	151	Q68DA7
RRSPLTSRHSGSTLA	INSYN1	241	Q2T9L4
LARARHSATGKRTTT	IQCE	616	Q6IPM2
QRKSTTLSGPHSTIR	NPAT	216	Q14207
HPSARKLTAQRRAST	NET1	526	Q7Z628
TLRGINSRHPSLAFK	FBXO21	231	O94952
PKSGSTVRRRQGTTH	FLG2	1301	Q5D862
RRSHAPQSRSSLNAK	KCND1	566	Q9NSA2
RHRLQATSHRKTSLP	LNP1	36	A1A4G5
GRGSHKRSRSVPSSL	LSM11	271	P83369
KLHFSRPQTIGAASR	MTO1	656	Q9Y2Z2
SQNSSKRRAVLPRSH	FAM86JP	6	Q05BU3
SLHSGASRRSQKRLQ	ERN2	481	Q76MJ5
KSRQASVGDRRSPST	KCNQ5	436	Q9NR82
TSPGSLRKQRSSQHG	DCLK1	336	O15075
GSPRRTSRVSGHTKI	GJD4	276	Q96KN9
RSLQSLLGPSSKFRH	CORO7	461	P57737
TGSSSRGKRKRQQHP	GPATCH4	411	Q5T3I0
HPIRGRAKSRSLSAS	NADK	36	O95544
QRGRAASHSRALTLP	PCNX3	616	Q9H6A9
HSKTFKRSTLSSRGP	PCSK6	111	P29122
KRSTLSSRGPHTFLR	PCSK6	116	P29122
TSTPHNTRRVAALRG	PDZD2	1311	O15018
LSRSRGRHSMTRAPK	PDE4C	16	Q08493
KSQSHPALERGSQRR	CUL7	1431	Q14999
ARKRRLSSTSLASGH	PRKD2	191	Q9BZL6
TSLLTSAGNRTHKAR	ADAMTSL2	536	Q86TH1
TLPRKSSSFLIHGRQ	EXPH5	1021	Q8NEV8
RTLSRSSRSNGRHLK	ABCC2	911	Q92887
SSRSNGRHLKSLRNS	ABCC2	916	Q92887
RTSSRVLRASQHPKK	KIAA1549L	611	Q6ZVL6
SVRALRATSGKRPSN	PSRC1	156	Q6PGN9
SRSSKRGASPSRHSI	PITPNM2	311	Q9BZ72
KYSHRARPARNTATR	PITPNM2	1256	Q9BZ72
SVSHGRSRIARLPSS	KIF18B	791	Q86Y91
SPSASRRKGRASEHK	NOC2L	56	Q9Y3T9
GSSHTLPRRAQSLKA	RICTOR	1291	Q6R327
QKHRQSPDSGRTRTK	KDM5A	806	P29375
TPVQGRLKSHSRDRN	KLHL4	46	Q9C0H6
SRPLSSFVQKARHRR	POM121C	76	A8CG34
QLHGESPTRRLQRSK	RIMS2	951	Q9UQ26
SKPRHRRGNSRGSHS	MAP3K13	586	O43283
ENGHRKRSSRPASAS	NCOA6	2031	Q14686
LRHKSSLSRRTSSAG	PPP1R16B	326	Q96T49
RIESRHSASKSRQTP	ORC1	211	Q13415
LRIPTSRGRHKAFST	OR6P1	226	Q8NGX9
STSRAHKLPSRRQPG	FAM189A2	391	Q15884
SKRHRSRALGVQTPS	FRG2B	156	Q96QU4
SKRHRSRALGVQTPS	FRG2	156	Q64ET8
GQQRSRSLHRPAKTS	APC2	1836	O95996
RGPVQKSSHRSGFIR	EPB41L5	326	Q9HCM4
SKHPGTAASRQSIRR	HEATR5A	246	Q86XA9
HRARSRSNKATTLPD	C2CD3	1976	Q4AC94
VRKQVSRERSGSPHS	DOCK6	21	Q96HP0
GRNVPNSRHKSLRTV	BRCA2	106	P51587
STPVLRRNRIHSGKQ	FBXO11	626	Q86XK2
HFSKSLRPSLNGRRI	FILIP1L	776	Q4L180
ISRNLTKIAPGHSRF	C19orf44	36	Q9H6X5
QKPTSTRAAIRSHGS	FRS3	371	O43559
KTSSLKPAVTRRSHR	FAM172A	396	Q8WUF8
GTTRTRPRNGTLNKH	ILK	171	Q13418
SGSTHRSPRSFLAKK	CDC42EP1	71	Q00587
ETRTSSRLHLKRAPG	CYBC1	6	Q9BQA9
TKPNGTLSHKSGRRR	MAK	381	P20794
THSTKRGHAKSRPVR	FGA	616	P02671
ARLRSNSIGARHSTP	MAST3	841	O60307
RQRRGKESLRSSPHK	MAST4	2606	O15021
TSINKSPQRDSGRHR	INSRR	731	P14616
RPHLSGRKLSLQERS	CAMKK2	91	Q96RR4
HSKTRRGSSLRSEPS	FAM47A	341	Q5JRC9
GSMLRRPRTSSQHAS	GBF1	1456	Q92538
ASKHRRGLSSSALPR	KLB	791	Q86Z14
KVHRFPRSSRSVRSV	KLF15	401	Q9UIH9
RTRKRKQSGHSPARA	DDIT3	101	P35638
RKQLAAGRPHTRSTV	CAND2	976	O75155
QPSRKSGSRKRNHSP	CD244	321	Q9BZW8
APSGRRITNKCRSSH	MAP3K19	691	Q56UN5
RSQKHTRAQTGPTAT	FTH1P19	141	P0C7X4
SPHSGVSRQVRIKAS	MAP3K3	131	Q99759
KRRRGPASSHCQLTL	POM121L1P	136	Q3SYA9
STQGPRATKHALLRT	PARP10	266	Q53GL7
ESPNGSRKRRSSTVA	KIF23	901	Q02241
HSPKISQRRTRRDAA	MCM9	951	Q9NXL9
SNVRGKRHGSSRKSS	GARIN3	486	Q8TC56
QNRARHSSRKPTTSK	RHNO1	76	Q9BSD3
GASRKRTRSRSPHEK	SFSWAP	836	Q12872
GRLRSIHTSSKTALR	TRIM42	106	Q8IWZ5
THRLSKLSERRPSVQ	TEX55	211	Q96M34
SGRKHSVRLCSPRQA	PLEKHH3	171	Q7Z736
SPTSKNRSHGRAKRD	SRRM2	456	Q9UQ35
KSHSHTPSRRMGRSR	SRRM2	471	Q9UQ35
KRGRSRSRTPTKRGH	SRRM2	491	Q9UQ35
HPPKSRTARRGSRSS	SRRM2	1661	Q9UQ35
RSRPSIKRGASLHSS	TMCC2	156	O75069
SSGSKNRSRSHPRAP	TMEM200C	106	A6NKL6
HVFRRKTASSRSILP	LRRC27	306	Q9C0I9
SPQHKLSERGRSRLS	NHS	571	Q6T4R5
ARQLLGRLKPSHTSR	MYBL2	681	P10244
RPSVSHGRAQLLRKS	ODAD2	401	Q5T2S8
RLALSRRSHANGVKP	PELI3	91	Q8N2H9
GTRSPRTAHEISLKR	NCOR1	1231	O75376
NHTSRPRLKNVDRST	RYBP	141	Q8N488
RGHPSFQSLVSKLRS	SMG9	461	Q9H0W8
LRLRQVSGPLTSKRH	SHBG	151	P04278
VSKSSRNIPRRHTLG	KIAA1217	56	Q5T5P2
VHVRSRSSPATADKR	SHROOM3	1236	Q8TF72
HDSRSQRAASSRPIK	SAMD10	66	Q9BYL1
SPSRASKRHQRVLAT	STARD9	1036	Q9P2P6
SHSQRIAGSKLSPRL	ITGAM	566	P11215
TRRPAATRQGHSTAV	OLFML2B	346	Q68BL8
SGKKSRSQSRSPHRS	U2SURP	1006	O15042
VSQHPRTKSSRLQGS	APC	1326	P25054
KYRASSSRRAVTPRH	CHST8	166	Q9H2A9
VRLTSRHSGAAKTRT	PGBD2	431	Q6P3X8
TSKGRRLHLAPRASL	TMTC4	136	Q5T4D3
KVRFQASIHLGPSRS	UCP3	141	P55916
LRRFTRPEHLGSSAK	USP22	366	Q9UPT9
PAATAKSHLSLRRRQ	ZC3H3	466	Q8IXZ2
RSRVSASHGPRKPSA	ZC3H3	821	Q8IXZ2
SSVRRHKRTHTGEKP	ZNF441	321	Q8N8Z8
KRSLKRGLPRSHSVS	TICRR	926	Q7Z2Z1
RRSPRIKQLSFSRTH	TICRR	1011	Q7Z2Z1
EKTVRRSRASLHPQA	ZNF324	506	O75467
RSRASLHPQARSVAG	ZNF324	511	O75467
GKTFPRTSSLNRHVR	ZNF555	206	Q8NEP9
GSSTPRISHRRNKHA	SSH2	56	Q76I76
SPRRSRSGSQKRTHS	SRRM5	286	B3KS81
SQLGSPSKERDHRRS	SRRM5	486	B3KS81
TFKSPHIRRLSGIRA	TMPRSS7	341	Q7RTY8
VKATGPALRRLHTSS	MRPL55	16	Q7Z7F7
RSRDRKPGSHASSSA	SCAF1	556	Q9H7N4
LGTSQRRRKSLPVHN	SPATA31D1	1311	Q6ZQQ2
RRSPSLSSKHRKGSS	SRRM1	651	Q8IYB3
ESRSGSRSPSRVSKH	TRA2A	31	Q13595
GAKGTRSRSSHARPV	VASH2	16	Q86V25
RLKSRASHTRTPSRA	nan	81	A8MUU9
LKSRASHTRTPSRAS	nan	181	A8MUU9
PEHSASARKLSRRRT	BRF1	561	Q92994
HRLRGSLTAIKTRAP	TIMM17A	46	Q99595
SPARRRAKSSQHLLT	VXN	26	Q8TAG6
RGLRHSSAKVRSRTA	XPOT	531	O43592
PKHSRSRSVEKSQRS	PNISR	776	Q8TF01
TSKSRERHNSPSRGR	ZRSR2P1	416	Q15695
LGNRKHPRSFSTSST	TRPC5	761	Q9UL62
VPSSSGRHEGRTTKR	WNK1	1086	Q9H4A3
SLLPGFRSRSRNVKH	THSD7B	356	Q9C0I4
RQKLSSRHSRSQGAS	THSD4	191	Q6ZMP0
TSRPNMKRHRRTHTG	ZNF652	451	Q9Y2D9
SGKSARHTPARSRSK	TRA2B	26	P62995
PVEKSHGRLQNRTSR	SPATA6	171	Q9NWH7
RSQVRRQSLASKHGS	ZRANB3	1056	Q5FWF4
SLRHGSNSQRISRGK	NALCN	766	Q8IZF0
KRSSRRVQRHNSFSP	NECAB1	181	Q8N987